When It May Not Be Necessary To Model Overall Survival for Economic Evaluations of Anti-Cancer Drugs
Value Health
.
2014 Nov;17(7):A584.
doi: 10.1016/j.jval.2014.08.1983.
Epub 2014 Oct 26.
Authors
M Hoyle
1
,
W Hamilton
1
,
C Rudin
2
Affiliations
1
University of Exeter, Exeter, UK.
2
Royal Devon & Exeter Hospital, Exeter, UK.
PMID:
27201977
DOI:
10.1016/j.jval.2014.08.1983
No abstract available